DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)" report to their offering.
The global Lupus Nephritis market is set to experience favorable growth driven by factors such as increasing African-American population, rising health care expenditure and accelerating economic growth. The major trends observed in the market are new drugs under pipeline for Lupus Nephritis, increasing research grants with rising public awareness about the disease. However, the growth of this budding market will be hindered by stringent regulations, associated risk and high cost.
The treatment for Lupus Nephritis is based upon on its type, which is determined by the biopsy. Since, symptoms and severity vary from person to person, treatments are individually tailored to meet a person's particular circumstances.
The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report.
The five major players: Aurinia Pharmaceuticals Inc., Roche Holding AG, Bristol-Myers Squibb, GlaxoSmithKline Plc. and AstraZeneca are being profiled along with their key financials and strategies for growth.
Key Topics Covered:
2. Global Market Analysis
3. Regional Market Analysis
4. Market Dynamics
6. Company Profiles
- Aurinia Pharmaceuticals Inc.
- Roche Holding AG
- Bristol-Myers Squibb
- GlaxoSmithKline Plc.
For more information about this report visit http://www.researchandmarkets.com/research/x7f28t/global_lupus